GeorgeJ.HuttonMD

Neurology • Houston, TX

Neuroimmunology/Multiple Sclerosis

Associate Professor, Neurology, Baylor College of Medicine

Join to view full profile

Dr. Hutton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hutton's full profile

Already have an account?

Office
6501 Fannin St
# NB100
Houston, TX 77030
Phone+1 713-798-5975

Fax+1 713-798-5864

Education & Training

Baylor College of MedicineResidency, Neurology, 1997 - 2000
Baylor College of MedicineInternship, Internal Medicine, 1996 - 1997
Vanderbilt University School of MedicineClass of 1996

Certifications & Licensure

TX State Medical License 1997 - 2026
LA State Medical License 2020 - 2022
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Top Doctors:SE Texas Castle Connolly, 2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Super Doctor SuperDoctors.com

Clinical Trials

High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study Start of enrollment: 2006 Jul 01
Completed
Phase 2
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Start of enrollment: 2011 Sep 08
Completed
Phase 2
Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis Start of enrollment: 2011 Mar 01
Completed
Phase 3

Publications & Presentations

PubMed

Factors associated with the initiation of high-efficacy disease-modifying agents over moderate-efficacy disease-modifying agents in multiple sclerosis.
Jieni Li, George J Hutton, Tyler J Varisco, Ying Lin, Ekere J Essien
Multiple Sclerosis and Related Disorders. 2024-11-01
Increased Intracranial Pressure in Myelin-Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Torge Rempe, Aisha Elfasi, Samir Alkabie, Alison Christy, Elsa Rodriguez
The Neurologist. 2024-10-10
Frequency, characteristics, predictors and treatment of relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
Torge Rempe, Elsa Rodriguez, Aisha Elfasi, Samir Alkabie, Mayra Montalvo Perero
Multiple Sclerosis and Related Disorders. 2024-07-01

Press Mentions

MS Diagnosis: What to Know About Tests and Treatments for Multiple SclerosisNovember 12th, 2021